Clinical trial identifies safer, equally effective antibiotics for golden staph infections.

An international clinical trial, known as the SNAP Trial, has determined that cefazolin and benzylpenicillin are safer and equally effective alternatives to flucloxacillin for treating golden staph bloodstream infections. These significant findings, published in major medical journals, are anticipated to influence global treatment protocols for this life-threatening condition.